Company news
Chemical Works Of Gedeon Richter Plc (BET:RICHTER) news
Chemical Works Of Gedeon Richter Plc news releases on 6ix. Latest, Sep 4, 2026: Notification on change in voting rights
Press releases & updates
Notification on change in voting rights
September 4, 2026
Voting rights, registered capital
August 31, 2026
Transactions with Treasury Shares
August 28, 2026
Half-yearly Report 2026 H1
August 6, 2026
Richter and Adalvo Expand Global Co-Development Partnership in Tirzepatide Across Diabetes and Obesity Care
August 6, 2026
Bond interest payment
July 10, 2026
Gedeon Richter : Richter and Hetero Announce Global Cooperation for the Development and Commercialization of Semaglutide Injection (Generic of Ozempic®)
June 10, 2026
Gedeon Richter : Richter and Acrux agree to license Lenzetto® for Australia
May 27, 2026
Gedeon Richter : Transactions with Treasury Shares
May 14, 2026
Gedeon Richter : Interim management statement
May 12, 2026
Gedeon Richter : Richter publishes Q1 2026 results
May 12, 2026
Gedeon Richter : Richter receives European Commission approval for Tuyory®, its biosimilar tocilizumab in multiple indications
April 29, 2026
Gedeon Richter : Consolidated Financial Statements 2025 - Independent Auditor’s Report
April 7, 2026
Gedeon Richter : Separate Financial Statements 2025- Independent Auditor’s Report
April 7, 2026